ARTHEX BIOTECH
ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing antisense RNA treatments against genetic diseases. Our team has a strong background on drug discovery and microRNAs involvement in neuromuscular diseases. We are supported by world-renowned scientific and clinical advisors that will facilitate the successful development of our products.
ARTHEX BIOTECH
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Valencia, Comunidad Valenciana, Spain
Country:
Spain
Website Url:
http://www.arthexbiotech.com
Total Employee:
1+
Status:
Active
Contact:
+34 625 016 629
Email Addresses:
[email protected]
Total Funding:
62.95 M EUR
Technology used in webpage:
Person Schema Facebook Sharer Gravatar Profiles CrUX Dataset CrUX Top 10m WhatsApp
Similar Organizations
Anjarium Biosciences
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
Brighter
Data-driven solutions for smarter treatment of chronic conditions.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Recludix Pharma
Recludix pharma is a developing platform to treat cancer patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Series B - ARTHEx Biotech
Invivo Capital Partners
Invivo Capital Partners investment in Series B - ARTHEx Biotech
Centre for the Development of Industrial Technology (CDTI)
Centre for the Development of Industrial Technology (CDTI) investment in Series B - ARTHEx Biotech
Columbus Venture Partners
Columbus Venture Partners investment in Series B - ARTHEx Biotech
AdBio partners
AdBio partners investment in Series B - ARTHEx Biotech
Hadean Ventures
Hadean Ventures investment in Series B - ARTHEx Biotech
Sound Bioventures
Sound Bioventures investment in Series B - ARTHEx Biotech
European Innovation Council
European Innovation Council investment in Venture Round - ARTHEx Biotech
European Innovation Council
European Innovation Council investment in Grant - ARTHEx Biotech
Invivo Capital Partners
Invivo Capital Partners investment in Seed Round - ARTHEx Biotech
Official Site Inspections
http://www.arthexbiotech.com Semrush global rank: 5.12 M Semrush visits lastest month: 1.55 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "ARTHEx Biotech"
About - Arthex Biotech
About We are investigating antisense RNA compounds to treat diseases with unmet medical needsSee details»
ARTHEx Biotech - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +34 625 016 629 ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing antisense RNA treatments …See details»
ARTHEx Biotech Company Profile | Management and Employees …
Www.arthexbiotech.com . ARTHEx Biotech Profile and History. ARTHEx Biotech is a spin-off company of the University of Valencia. Established in September 2019, it is focused on …See details»
Arthex Biotech Company Profile 2024: Valuation, Funding
Arthex Biotech General Information Description. Developer of anti-microRNAs designed for the treatment of diseases with unmet needs. The company develops drugs and therapies that are …See details»
ARTHEx Biotech - LinkedIn
ARTHEx Biotech is a spin-off biotech company from the University of Valencia (Spain) focused on the research and development of novel oligonucleotide therapies that modulate microRNA to treat ...See details»
ARTHEx Biotech - Overview, News & Competitors | ZoomInfo.com
ARTHEx Biotech. Business Services · Spain · <25 Employees . ARTHEx Biotech is a spin-off company of the University of Valencia. Established in September 2019, it is focused on …See details»
ARTHEX BIOTECH S.L - European Commission
Arthex Biotech (“The Company”) was founded in 2019 by Dr. Beatriz Llamusi and Dr. Ruben Artero as a spin-off of the University of Valencia where they have researched rare diseases, more specifically myotonic dystrophy type 1 (DM1 …See details»
We are excited to welcome Arthex to our portfolio
For more information, please visit www.arthexbiotech.com and engage with us on LinkedIn. About Dr. Frédéric Legros. Before joining ARTHEx Biotech as Executive Chairman in November 2022, he served as Chief Operating Officer of …See details»
ARTHEx Biotech - Craft
ARTHEx Biotech is a company that develops antisense RNA treatments for genetic diseases. Its technology platform is based on the use of microRNAs (miRNAs), a class of non-coding RNA …See details»
ARTHEx Biotech - ASEBIO
ARTHEx is developing antisense RNA treatments against unmet genetic diseases. Our first product is a new first-in-class drug, which is an antisense RNA therapy addressed to the …See details»
Arthex Biotech - Products, Competitors, Financials, Employees ...
Arthex Biotech is a biotechnology company focused on the development of novel oligonucleotide therapies for diseases with unmet medical needs. Use the CB Insights Platform to explore …See details»
Continue reading - Arthex Biotech
May 3, 2023 For more information, please visit www.arthexbiotech.com and engage with us on LinkedIn. About Dr. Frédéric Legros Before joining ARTHEx Biotech as Executive Chairman in …See details»
Arthex Biotech - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
ARTHEx Biotech SL (ARTHEx Biotech SL) - 药物管线_专利_临床试 …
-ATX-01 is the industry’s first anti-microRNA therapeutic to be investigated in DM1 – VALENCIA, Spain I October 18, 2024 I ARTHEx Biotech S.L., a clinical-stage biotechnology company …See details»
ARTHEx Biotech finishes the year 2021 met another key milestone …
ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing antimiR treatments against degenerative muscular disorders.See details»
ARTHEx - Company Profile - Tracxn
6 days ago ARTHEx - Developer of oligonucleotide therapies for neuromuscular diseases. Raised a total funding of $8.03M over 8 rounds from 11 investors. Founded by Beatriz Llamusi …See details»
News & Events - Arthex Biotech
ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.See details»
Why Canada excels at medical tech startups - The Globe and Mail
1 day ago The incubator program at the University of Toronto’s Mississauga campus – which opened its doors to its first 15 startups in the first cohort in May – is one of the few in Canada …See details»
Continue reading - Arthex Biotech
Feb 28, 2024 Investor and MediaContact Frédéric Legros AmyConrad Executive Chairman and CEO JuniperPoint [email protected] [email protected] +33679495790 +1858 …See details»
Our Approach & Focus - Arthex Biotech
MicroRNAs (miRNAs) are a class of non-coding RNA molecules that play an essential role in the regulation of gene expression at the post-transcriptional level, by binding to target mRNAs and …See details»